CNBCMerck's Covid pill approved by UK regulator, a potential game changer in fighting the pandemicNov 4, 2021Holly EllyattBy Holly Ellyattmore_vert
Financial TimesPfizer's Covid antiviral pill slashes hospitalisation risk, trial showsNov 5, 2021Hannah Kuchler, Donato Paolo Mancini & Joe RennisonBy Hannah Kuchler, Donato Paolo Mancini & Joe Rennisonmore_vert
CBS NewsU.K. becomes first country to OK use of Merck antiviral drug to treat COVID-19Nov 4, 2021more_vert
The New York TimesCoronavirus: Covid News: Biden Aide Tests Positive for Coronavirus (Published 2021)Nov 16, 2021Dan Levin, Katie Rogers & Sharon OttermanBy Dan Levin, Katie Rogers & Sharon Ottermanmore_vert
The GuardianPfizer Covid pill ‘can cut hospitalisations and deaths by nearly 90%’Nov 5, 2021Ian SampleBy Ian Samplemore_vert
CNBCPfizer board member Gottlieb says the Covid pandemic could be over in the U.S. by JanuaryNov 5, 2021Robert ToweyBy Robert Toweymore_vert
BBC.comMolnupiravir: First pill to treat Covid gets approval in UKNov 4, 2021Jim ReedBy Jim Reedmore_vert
Reuters.comUK to roll out COVID-19 antiviral drug trial this month -Health Security AgencyNov 8, 2021Kylie MacLellanBy Kylie MacLellanmore_vert
STATExperimental Pfizer pill prevents Covid hospitalizations and deathsNov 5, 2021Matthew HerperBy Matthew Herpermore_vert
USA TODAYCOVID antiviral drug from Pfizer, Paxlovid, prevents deaths: StudyNov 5, 2021Karen WeintraubBy Karen Weintraubmore_vert
ForbesUK Approval Of Molnupiravir May Create New And More Dangerous Covid-19 VariantsNov 4, 2021William A. HaseltineBy William A. Haseltinemore_vert
ABC NewsPfizer's COVID-19 pill treatment reduces risk of being hospitalized or dying by 89%, company saysNov 5, 2021Sony SalzmanBy Sony Salzmanmore_vert
The GuardianUK first to approve oral antiviral molnupiravir to treat CovidNov 4, 2021Ian SampleBy Ian Samplemore_vert
NPRPfizer says its COVID-19 pill cuts disease's worst risks by 89%Nov 5, 2021Bill ChappellBy Bill Chappellmore_vert
Financial TimesMerck's Covid pill Lagevrio secures green light from UK regulatorNov 4, 2021Donato Paolo Mancini & Jamie SmythBy Donato Paolo Mancini & Jamie Smythmore_vert
BBC.comCovid: Pfizer says antiviral pill 89% effective in high-risk casesNov 5, 2021Philippa Roxby & Jim ReedBy Philippa Roxby & Jim Reedmore_vert
Reuters.comBiden says U.S. has secured doses of new Pfizer COVID pillNov 5, 2021Trevor Hunnicutt & Alexandra AlperBy Trevor Hunnicutt & Alexandra Alpermore_vert
Reuters.comBritain approves Merck's COVID-19 pill in world firstNov 4, 2021Pushkala AripakaBy Pushkala Aripakamore_vert
Reuters.comPfizer says its antiviral pill slashes risk of severe COVID-19 by 89%Nov 5, 2021Deena BeasleyBy Deena Beasleymore_vert
Reuters.comExplainer: How does Merck's COVID-19 pill compare to Pfizer's?Nov 7, 2021Deena BeasleyBy Deena Beasleymore_vert
CNBCPfizer says its Covid pill with HIV drug cuts the risk of hospitalization or death by 89%Nov 5, 2021Berkeley Lovelace & Berkeley Lovelace Jr.By Berkeley Lovelace & Berkeley Lovelace Jr.more_vert
STATMerck's Covid-19 antiviral pill receives first authorization in U.K.Nov 4, 2021Maria Cheng & Matthew PerroneBy Maria Cheng & Matthew Perronemore_vert
The New York TimesPfizer Says Its Antiviral Pill Is Highly Effective in Treating Covid (Published 2021)Nov 16, 2021Rebecca RobbinsBy Rebecca Robbinsmore_vert